Review Article
Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals
Table 2
The effects of phytochemicals on the tight junction barrier function.
| Treatment | Conc. | System | Stimuli | Tight junction protein affected | Potential targeting pathways | Ref. |
| Quercetin | 200 μM | Caco-2 | None | ↑ claudin-4 | ↓ protein kinase A (PKA) or PKG | [50] | 100 μM | Caco-2 | None | ↑ ZO-2, occludin, claudin-1 and -4 | ↓ PKCδ | [51] |
| Berberine | 100 μM | Caco-2 | None | Not studied | Not studied | [55] | 100 μM | Caco-2 | TNF-α, IFNγ | ↑ occludin | Not studied | [56] | 200 mg/kg | Mouse | LPS | ↑ occludin, ZO-1, claudin-1 and -4 | ↓ myosin light chain kinase, ↓ nuclear factor-κB (NF-κB) | [53] | 375 mg/kg/day | Rat | Streptozotocin | ↑ occludin, ZO-1, claudin-1 | ↓ TLR4/MyD88/NF-κB signaling pathways | [54] |
| Genistein | 300 μM | Caco-2 | None | Not studied | Localization of filamentous actin in the perijunctional area | [59] |
| Kaempferol | 100 μM | Caco-2 | None | ↑ occludin, claudin-1 and -3, and ZO-1; ↑ ZO-2 and claudin-4; phosphorylation of occludin | Not studied | [63] |
| Curcumin | 5 μM | Caco-2 | TNF-α | ↑ ZO-1 | ↓ NF-κB | [17] | 5 μM | Caco-2 | TNF-α | Not studied | ↓ myosin light chain kinase, ↓ NF-κB | [19] | 5 μM | Caco-2 | IL-1β | Not studied | ↓ NF-κB | [20] | 30 μM | Caco-2 BBe | Leptin | ↑ ZO-3, claudin-5, occludin | ↓ leptin signaling pathway | [67] |
|
|